Ocular Therapeutix (OCUL) Leases: 2019-2025
Historic Leases for Ocular Therapeutix (OCUL) over the last 7 years, with Sep 2025 value amounting to $5.3 million.
- Ocular Therapeutix's Leases fell 6.32% to $5.3 million in Q3 2025 from the same period last year, while for Sep 2025 it was $5.3 million, marking a year-over-year decrease of 6.32%. This contributed to the annual value of $5.9 million for FY2024, which is 8.14% down from last year.
- According to the latest figures from Q3 2025, Ocular Therapeutix's Leases is $5.3 million, which was down 9.33% from $5.9 million recorded in Q2 2025.
- In the past 5 years, Ocular Therapeutix's Leases ranged from a high of $8.0 million in Q4 2022 and a low of $4.0 million during Q3 2022.
- For the 3-year period, Ocular Therapeutix's Leases averaged around $6.3 million, with its median value being $6.0 million (2024).
- In the last 5 years, Ocular Therapeutix's Leases fell by 21.93% in 2022 and then skyrocketed by 71.53% in 2023.
- Over the past 5 years, Ocular Therapeutix's Leases (Quarterly) stood at $4.9 million in 2021, then skyrocketed by 65.24% to $8.0 million in 2022, then dropped by 19.52% to $6.5 million in 2023, then dropped by 8.14% to $5.9 million in 2024, then dropped by 6.32% to $5.3 million in 2025.
- Its Leases was $5.3 million in Q3 2025, compared to $5.9 million in Q2 2025 and $5.8 million in Q1 2025.